Conduit Pharmaceuticals Inc. (CDT) Earning

NASDAQ Currency in USD Disclaimer

$0.08

north_east $0.01 (15.6%)
Day's range
$0.06
Day's range
$0.08

Conduit Pharmaceuticals Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
10/31/2024 Q3 2024 $0.62 $244.00 M
08/12/2024 Q2 2024 -$0.07 $604.34 M
05/02/2024 Q1 2024 -$0.05 $535.68 M
12/30/2023 Q4 2023 $0.02 $0
09/29/2023 Q3 2023 $0.03 $0
06/29/2023 Q2 2023 -$0.40 $0
03/30/2023 Q1 2023 -$0.59 $0
12/30/2022 Q4 2022 -$0.18 $0
09/29/2022 Q3 2022 -$0.01 $0
06/28/2022 Q2 2022 -$0.01 $0
03/30/2022 Q1 2022 -$0.00 $0
12/29/2021 Q4 2021 -$0.00 $0
 

Conduit Pharmaceuticals Inc. Earnings: FAQ's

When is Conduit Pharmaceuticals Inc.'s earnings date?

Conduit Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 18th, 2024 based off last year's report dates.

How can I listen to Conduit Pharmaceuticals Inc.'s earnings conference call?

The conference call for Conduit Pharmaceuticals Inc.'s latest earnings report can be listened to online.

How can I read Conduit Pharmaceuticals Inc.'s conference call transcript?

The conference call transcript for Conduit Pharmaceuticals Inc.'s latest earnings report can be read online.

How much profit does Conduit Pharmaceuticals Inc. generate each year?

Conduit Pharmaceuticals Inc. (:CDT) has a recorded net income of $0. Conduit Pharmaceuticals Inc. has generated $-0.0904 earnings per share over the last four quarters.

What is Conduit Pharmaceuticals Inc.'s price-to-earnings ratio?

Conduit Pharmaceuticals Inc. (:CDT) has a price-to-earnings ratio of -0.48 and price/earnings-to-growth ratio is -0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED